(EMAILWIRE.COM, November 20, 2018 ) According to the new market research report "Cardiac Monitoring Market" worth USD 25.12 Billion by 2022
Browse 170 market data Tables and 31 Figures spread through 180 Pages and in-depth TOC on "Cardiac Monitoring & Cardiac Rhythm Management Devices Market by Product (ECG, Cardiac Output Monitoring, ILR), CRM [ICDs, External Defibrillator, Pacemaker (Dual Chamber Pacemaker)], End User (Home and Ambulatory, Hospital) - Global Forecast to 2022"
https://www.marketsandmarkets.com/Market-Reports/cardiac-monitoring-advanced-technologies-and-global-market-55.html
Factors such as the increasing incidence of cardiovascular diseases and technological advancements in devices are expected to propel the growth of the market. However, price sensitivity and limited reimbursements for remote cardiac monitoring devices are expected to restrain the growth of the CM & CRM devices market.
Objectives of the Study
· To define, describe, and forecast the cardiac monitoring market by product, end user, and region
· To provide detailed information regarding the major factors influencing market growth (drivers, restraints, opportunities, and challenges)
· To analyze micro markets with respect to individual growth trends, prospects, and contributions to the overall market
· To analyze market opportunities for stakeholders and to provide details of the competitive landscape for market leaders
· To forecast the size of the cardiac monitoring market in North America, Europe, Asia, and the Rest of the World
· To profile key players and comprehensively analyze their core competencies
· To track and analyze competitive developments such as product launches, agreements, partnerships, and other developments in the cardiac monitoring and cardiac rhythm management devices market
The hospitals segment accounted for the largest share of the cardiac monitoring and cardiac rhythm management devices market in 2017.The external defibrillators segment is expected to grow at the highest CAGR in defibrillators market during the forecast period. Asia is expected to grow at the highest CAGR during the forecast period
Download Free Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=55
In 2017, North America accounted for the largest share of the cardiac monitoring and cardiac rhythm management devices market. Asia is expected to register the highest growth rate from 2017 to 2022 for the cardiac monitoring and cardiac rhythm management devices market. The large share of this regional segment can be attributed to the growth in the geriatric population and the subsequent growth in the prevalence of cardiovascular diseases, high accessibility to advanced technologies, increasing development of innovative and technologically advanced products, and increasing healthcare expenditure in the region.
Market Players
Major key players in the cardiac monitoring and cardiac rhythm management devices market include Medtronic (Ireland), Abbott (US), Boston Scientific (US), BIOTRONIK (Germany), GE Healthcare (US), and Philips Healthcare (Netherlands). In the highly competitive CM and CRM devices market, a majority of the leading players aim to gain a competitive edge through technological advancements and new product launches.
Target Audience
· Government and Academic Institutes
· Research Laboratories, Diagnostic Centers, and Research Institutes
· Cardiac Monitoring and Cardiac Rhythm Management Device Manufacturers
· Suppliers and Distributors of CM and CRM Devices
· Monitoring Service Providers
· Healthcare Service Providers
· Physicians
· Diagnostic Centre’s

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
newsletter@marketsandmarkets.com